Bangladesh-based Square Group companies, Square Pharmaceuticals PLC and Square Textiles PLC, reported higher profits during the July–September quarter of 2026, supported by revenue growth and improved business performance.

Square Pharmaceuticals recorded a 5% year-on-year increase in quarterly profit to Tk 778 crore. The company reported net revenue of Tk 2,244 crore, representing a 4% increase compared with the same quarter last year.

Its earnings per share (EPS) increased to Tk 8.77 from Tk 8.35 in July–September 2025. However, net operating cash flow per share (NOCFPS) declined to Tk 5.49 from Tk 7.55 a year earlier.

According to the company's disclosure on the Dhaka Stock Exchange (DSE), the decline in operating cash flow was mainly due to higher payments to suppliers, increased manufacturing and operating expenses, and higher income tax payments. These costs grew faster than cash collections from customers.

Square Textiles Profit Rises 28%

Square Textiles reported a stronger performance, with quarterly profit increasing 28% year-on-year to Tk 42.83 crore. Its revenue reached Tk 669 crore, registering 10% growth compared with the corresponding period of 2025.

The company's earnings per share increased to Tk 2.17 from Tk 1.69. According to its disclosure to the Dhaka Stock Exchange, the improvement in EPS was primarily driven by an increase in yarn prices.

However, Square Textiles also reported a decline in operating cash flow, with NOCFPS standing at negative Tk 3.66 compared with negative Tk 0.90 in the same quarter last year, indicating higher operating cash outflows.

The financial results highlight the positive earnings performance of two major Square Group businesses. While higher yarn prices supported Square Textiles' profitability, declining operating cash flow remains an important factor to monitor for both companies.